Vichinsky E, Hoppe CC, Ataga KI, et al. Results from the randomized placebo-controlled phase 3 HOPE trial of voxelotor in adults and adolescents with sickle cell disease. 24th Congress of EHA, abstract S147.
Conditionele overleving bij Waldenström neemt af naarmate patiënt langer leeft
mrt 2022 | Lymfoom